{"nct_id":"NCT04762498","title":"A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2021-01-26","start_date_type":"ACTUAL","primary_completion_date":"2023-05-18","primary_completion_date_type":"ACTUAL","completion_date":"2023-12-20","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["AMGN"]}